1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) January 5, 1998
BIO-PLEXUS, INC.
(Exact name of Registrant as specified in its Charter)
Connecticut 0-24128 06-1211921
----------- ------- ----------
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
129 Reservior Road, Vernon, Connecticut 06066
(Address of Principal Executive Offices) (zip code)
(860) 870-6112
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
2
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS
Effective January 5, 1998, the registrant dismissed its former
independent accountants, Price Waterhouse LLP of Hartford, Connecticut and
engaged Mahoney Sabol & Company, LLP of Hartford, Connecticut as its independent
accountants.
During the two most recent audited fiscal years of the registrant and
through January 5, 1998, there have been no disagreements with Price Waterhouse
LLP on any matter of accounting principles or practices, financial statement
disclosure or auditing scope or procedure, which disagreements if not resolved
to the satisfaction of Price Waterhouse LLP would have caused them to make
reference thereto in their report on the financial statements for such years.
The reports of the former independent accountants on the financial
statements of the registrant for fiscal years ended December 31, 1995 and 1996
contained no adverse opinion or disclaimer of opinion, nor were qualified or
modified as to uncertainty, audit scope, or accounting principles, except that
on the December 31, 1996 financial statements, the opinion dated April 11, 1997,
contained an explanatory paragraph relating to the registrant's ability to
continue as a going concern.
The decision to change accountants was approved by the Board of
Directors of the registrant.
The registrant has provided Price Waterhouse LLP with a copy of this
disclosure and has requested that Price Waterhouse LLP furnish it with a letter
addressed to the SEC stating whether or not it agrees with the above statements.
A copy of such letter, dated January 5, 1998 is filed as Exhibit 16 to this Form
8-K.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIO-PLEXUS, INC.
By /s/ Richard L. Higgins
-------------------------------------
Richard L. Higgins
President and Chief Executive Officer
Date
-------------------------------------
4
BIO-PLEXUS, INC.
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
- ----------- -----------
16 Predecessor Accountants' Letter to SEC